RPL22L1 and LY96 are closely associated with enhanced VEGF signaling in T-cells from patients with PsA and RA, which may be one of the mechanisms by which T-cells are persistently activated and lead to inflammatory responses. This evidence concerns the gene RPL22L1 and rheumatoid arthritis.